CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 89 enrolled
Drug / intervention
Clinical Reminderbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01217827
NCT01217827Phase 3Completed

Implantable Cardioverter-Defibrillator (ICD) Utilization in a Potentially Eligible VA Population

Stanford University·interventional·Posted Oct 8, 2010·Updated May 19, 2021

In Brief

A Phase 3 clinical trial evaluating Clinical Reminder for Cardiomyopathies. Completed, enrolled 89 participants across 2 sites.

Detailed Summary

Despite being a proven life-saving intervention in appropriately selected individuals, multiple studies continue to demonstrate low implantation of defibrillators in potential candidates. Based upon prior research, a major barrier to low utilization is low referral of potential candidates by healthcare providers. In this study, via brief clinical reminder placed in the electronic medical record, we ask healthcare providers who have not referred potential candidates for defibrillator the reasons for this decision and provide them with the tools for referral if appropriate.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

Phase 3CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedOct 8, 2010
Enrollment StartApr 1, 2010
Primary CompletionJan 1, 2011
Study CompletionDec 1, 2013
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 15.7 years ago

Interventions

Clinical Reminderbehavioral